Filed in All
on August 27, 2013 with no comments
- Interesting to know what’s on neuroscientific radar screens, but impractical in the treatment room because we treat in the here and now.
- Moves at a “laboratory” pace – very slow.
- Subject to the vagaries of funding.
- Disappoints often – the complexity of brain functioning has defeated the DSMs and even the best NIMH efforts in search of valid and reliable biomarkers.
- Progress in understanding mental disorders is painstaking – they’ll be no holes-in-one, no all-encompassing explanations, nothing “Einsteinish.”
- There will be some pars, maybe an occasional birdie, and lots of water balls – true in all of medicine though.
- If we’re still fighting the war on cancer and losing most of the battles, how many orders of magnitude more challenging will it be to understand what is called schizophrenia?
Joseph Wegmann, R.Ph., LCSW is a licensed clinical pharmacist and a clinical social worker with more than thirty years of experience in the field of psychopharmacology. His diverse professional background in psychopharmacology and counseling affords him a unique perspective on medication management issues. In addition to consulting with numerous psychiatric facilities, he has presented psychopharmacology seminars to thousands of clinicians in 46 states.